Cytarabine-induced acral erythema: a localized form of toxic epidermal necrolysis?
Calista
D
D
Landi
C
C
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004890:Erythema / Q000139:chemically induced* / Q000473:pathology*; D006229:Hand Dermatoses / Q000139:chemically induced / Q000473:pathology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009336:Necrosis
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine